Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
18.09
0.92 (5.36%)
At close: Aug 15, 2025, 1:07 PM

Stoke Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
127.98M 191.44M 113.56M 144.9M
Short-Term Investments
88.92M 9.95M 116.04M 74.92M
Long-Term Investments
29.82M 569K 569K 569K
Other Long-Term Assets
721K n/a n/a n/a
Receivables
700K 64K 588K 132K
Inventory
n/a n/a 10.93M n/a
Other Current Assets
4.04M 2.56M -7.98M 2.33M
Total Current Assets
232.76M 215.34M 244.07M 229.22M
Property-Plant & Equipment
8.25M 12.43M 11.43M 9.08M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
38.8M 13M 12M 9.65M
Total Assets
271.56M 228.34M 256.07M 238.87M
Account Payables
2.5M 1.7M 766K 2.38M
Deferred Revenue
18.99M 15.31M 14.88M n/a
Short-Term Debt
2.32M 2.06M 2.36M 1.51M
Other Current Liabilities
6.12M 4.41M 5.28M -967K
Total Current Liabilities
40.06M 30.82M 31.39M 17.14M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
26K 4.88M 2.97M 417K
Total Long-Term Liabilities
2.48M 37.96M 39.82M 3.95M
Total Liabilities
42.53M 68.78M 71.22M 21.09M
Total Debt
2.32M 2.06M 2.36M 1.51M
Common Stock
5K 5K 4K 4K
Retained Earnings
-490.83M -401.85M -297.15M -196.08M
Comprehensive Income
-151K -24K -1.18M -168K
Shareholders Equity
229.02M 159.56M 184.85M 217.78M
Total Investments
118.74M 9.95M 116.04M 74.92M